Crossref
An AI-Guided Biparatopic B7H3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy
European Journal of Cancer · 2026-11 · 248 · 117502
DOI: 10.1016/j.ejca.2026.117502 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Y. Wu und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wu, Y., Jiang, S., Yang, B., Liu, D., Shang, Y., Tian, J., Chen, Z., Ran, H., Tian, L., Peng, J., & Zhu, Z. (2026). An AI-Guided Biparatopic B7H3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy. European Journal of Cancer, 248, 117502. https://doi.org/10.1016/j.ejca.2026.117502
Vancouver
Wu Y, Jiang S, Yang B, Liu D, Shang Y, Tian J, et al. An AI-Guided Biparatopic B7H3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy. European Journal of Cancer. 2026;248:117502. doi:10.1016/j.ejca.2026.117502
BibTeX
@article{Wu2026,
author = {Wu, Y. and Jiang, S. and Yang, B. and Liu, D. and Shang, Y. and Tian, J. and Chen, Z. and Ran, H. and Tian, L. and Peng, J. and Zhu, Z.},
title = {An AI-Guided Biparatopic B7H3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117502},
doi = {10.1016/j.ejca.2026.117502}
}
EUVIMED